相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions
Jonathan Zurawski et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosis
Martina Absinta et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Lesley A. Ward et al.
JCI INSIGHT (2020)
Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis
Suyog Pol et al.
EXPERIMENTAL NEUROLOGY (2019)
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
Philipp Haselmayer et al.
JOURNAL OF IMMUNOLOGY (2019)
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis
Xavier Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement
Pavan Bhargava et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Neutrophils promote VLA-4-dependent B cell antigen presentation and accumulation within the meninges during neuroinflammation
Chelsea R. Parker Harp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Chronic Inflammation: A Common Promoter in Tertiary Lymphoid Organ Neogenesis
Shanshan Luo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Microglial control of astrocytes in response to microbial metabolites
Veit Rothhammer et al.
NATURE (2018)
Leptomeningeal inflammation in multiple sclerosis: Insights from animal and human studies
Cassie Wicken et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Intrathecal treatment trial of rituximab in progressive MS An open-label phase 1b study
Joakim Bergman et al.
NEUROLOGY (2018)
Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study
Robert Zivadinov et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study
Robert Zivadinov et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume
Daniel M. Harrison et al.
JOURNAL OF NEUROIMAGING (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases
Martina Absinta et al.
NEUROLOGY (2017)
Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis
Gleb Makshakov et al.
NEUROLOGY RESEARCH INTERNATIONAL (2017)
The effects of intrathecal rituximab on biomarkers in multiple sclerosis
Joanne Topping et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
Mika Komori et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Integration of Th17-and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation
Natalia B. Pikor et al.
IMMUNITY (2015)
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis
Martina Absinta et al.
NEUROLOGY (2015)
Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space
O. W. Howell et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation
Jae Kyu Ryu et al.
NATURE COMMUNICATIONS (2015)
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
Anders Svenningsson et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide
Joan Ni Gabhann et al.
PLOS ONE (2014)
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE
Alison L. Christy et al.
JOURNAL OF AUTOIMMUNITY (2013)
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
Sung R. Choi et al.
BRAIN (2012)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis
Lucas Schirmer et al.
BRAIN PATHOLOGY (2011)
Inflammatory Cortical Demyelination in Early Multiple Sclerosis
Claudia F. Lucchinetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Gradient of Neuronal Loss and Meningeal Inflammation in Multiple Sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2010)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
B Serafini et al.
BRAIN PATHOLOGY (2004)
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
R Magliozzi et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Axonal damage: a key predictor of outcome in human CNS diseases
IM Medana et al.
BRAIN (2003)
FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis
K Tsuchiya et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2001)
分享论文
